Niche MRI vendor Advanced MammographySystems will debut its long-awaited MR mammography scanner atthe RSNA show. The company, which is a subsidiary of fast MRIdeveloper Advanced NMR Systems, will also hold a special briefingon Sunday, Nov. 27, to unveil
Niche MRI vendor Advanced MammographySystems will debut its long-awaited MR mammography scanner atthe RSNA show. The company, which is a subsidiary of fast MRIdeveloper Advanced NMR Systems, will also hold a special briefingon Sunday, Nov. 27, to unveil the unit.
AMS has yet not released the name of the system, but the scannerfeatures a 0.5-tesla superconducting magnet similar in appearanceto a standard MRI scanner, according to Robert Kwolyk, vice presidentof sales and marketing for the Wilmington, MA, company. Thereare significant differences, however: Patients will enter themagnet bore feet first and in a prone position, with the breastshanging through holes in the patient table. The scanner's specialradio-frequency coils are embedded within the table, Kwolyk said.
The scanner will feature sequences optimized for breast imaging,according to Kwolyk. The company is reluctant to discuss whetherthe scanner will be used for screening, lesion differentiationor both, preferring instead to leave the development of clinicalapplications up to physicians. Use of the scanner for imagingleaks in silicone breast implants is one application whose utilityis already evident, however.
The scanner has been designed to support an integrated breastbiopsy capability that may be developed in the future, accordingto Kwolyk. It may also be possible to integrate breast therapywith the system.
Advanced Mammography Systems has designed the system for cost-effectivescanning, Kwolyk said. The price of the system will probably beunder $500,000 and the scanner can complete an examination in15 minutes. The system sites in less than 300 square feet. Thecompany is in the process of filing a 510(k) application for theproduct.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.